Patricia Wahl

University of Miami — United States

Medicine · Health Sciences

50h-index10.3kcitations113works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes, Cardiovascular Risks, and Lipoproteins(38), Lipoproteins and Cardiovascular Health(21), Parathyroid Disorders and Treatments(10), Liver Disease Diagnosis and Treatment(9), Adipokines, Inflammation, and Metabolic Diseases(9)

Publications113 total

Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis
PLoS ONE·2019· 29 citedOpen Access
Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis
Kidney International·2018· 86 cited
Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury
Journal of Clinical Investigation·2016· 190 citedOpen Access
Prediction of Individual Response to Electroconvulsive Therapy via Machine Learning on Structural Magnetic Resonance Imaging Data
JAMA Psychiatry·2016· 272 cited
Systemic and renal lipids in kidney disease development and progression
American Journal of Physiology-Renal Physiology·2015· 142 citedOpen Access
Fibroblast Growth Factor 23 and Incident CKD in Type 2 Diabetes
Clinical Journal of the American Society of Nephrology·2014· 27 citedOpen Access
Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
Clinical Journal of the American Society of Nephrology·2013· 146 citedOpen Access
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Kidney International·2013· 329 citedOpen Access
Earlier Onset and Greater Severity of Disordered Mineral Metabolism in Diabetic Patients With Chronic Kidney Disease
Diabetes Care·2012· 75 citedOpen Access
FGF23 in Chronic Kidney Disease
Advances in experimental medicine and biology·2012· 71 cited
Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis
Clinical Journal of the American Society of Nephrology·2011· 85 citedOpen Access
344 Disordered Mineral Metabolism in CKD: Earlier Onset & Greater Severity of Diabetes
American Journal of Kidney Diseases·2011
122 Relationships Between FGF23, Dietary Phosphorus, Urinary Phosphate and Vascular Stiffness
American Journal of Kidney Diseases·2011· 1 cited
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Kidney International·2011· 1.2k citedOpen Access
Posttransplant Acidosis and Associated Disorders of Mineral Metabolism in Patients With a Renal Graft
Transplantation·2007· 51 cited
Preventing diabetes — applying pathophysiological and epidemiological evidence
British Journal Of Nutrition·2000· 37 cited
Clustering of Procoagulation, Inflammation, and Fibrinolysis Variables with Metabolic Factors in Insulin Resistance Syndrome
American Journal of Epidemiology·2000· 418 cited
Type 2 diabetes and the metabolic syndrome in Japanese Americans
Diabetes Research and Clinical Practice·2000· 76 cited
Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
Diabetes Care·1999· 293 cited
Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria
The Lancet·1999· 197 cited
page 1 of 6Next →

Frequent Co-authors

Wilfred Y. Fujimoto(13), Donna L. Leonetti(12), Laura Newell‐Morris(8), Richard W Bergstrom(7), Myles Wolf(6), Tamara Isakova(5), Carolyn E. Walden(5), Robert H. Knopp(5), John J. Albers(5), Edward J. Boyko(5), William P. Shuman(5), Robert O. Bergelin(5), Huiliang Xie(4), Joanne Hoover(4), William R. Hazzard(4), James L. Kinyoun(4), Walter C. Stolov(4), Orlando M. Gutiérrez(3), Julia J. Scialla(3), Lewis H. Kuller(3)